281 related articles for article (PubMed ID: 25672708)
1. [Fisher syndrome and Bickerstaff brainstem encephalitis].
Kuwabara S
Rinsho Shinkeigaku; 2014; 54(12):1056-7. PubMed ID: 25672708
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.
Latov N
Nat Rev Neurol; 2014 Aug; 10(8):435-46. PubMed ID: 24980070
[TBL] [Abstract][Full Text] [Related]
3. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
4. [Advances and perspectives in treatment for refractory neuropathies with special reference to immune-mediated neuropathies and Crow-Fukase syndrome].
Kuwabara S
Rinsho Shinkeigaku; 2010 Apr; 50(4):219-24. PubMed ID: 20411803
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of idiopathic inflammatory neuropathies.
Donofrio PD
Muscle Nerve; 2003 Sep; 28(3):273-92. PubMed ID: 12929187
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
Sederholm BH
Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
[TBL] [Abstract][Full Text] [Related]
7. Immune-Mediated Neuropathies.
Gwathmey KG; Smith AG
Neurol Clin; 2020 Aug; 38(3):711-735. PubMed ID: 32703478
[TBL] [Abstract][Full Text] [Related]
8. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
Radziwill AJ; Kuntzer T; Steck AJ
Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
[TBL] [Abstract][Full Text] [Related]
9. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
Brannagan TH
Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
[TBL] [Abstract][Full Text] [Related]
10. Immune-mediated neuropathies.
Kieseier BC; Mathey EK; Sommer C; Hartung HP
Nat Rev Dis Primers; 2018 Oct; 4(1):31. PubMed ID: 30310069
[TBL] [Abstract][Full Text] [Related]
11. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
Pascual-Pascual SI
Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of refractory Guillain-Barré syndrome with alemtuzumab in a patient with chronic lymphocytic leukemia.
Tzachanis D; Hamdan A; Uhlmann EJ; Joyce RM
Acta Haematol; 2014; 132(2):240-3. PubMed ID: 24853856
[TBL] [Abstract][Full Text] [Related]
13. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
[TBL] [Abstract][Full Text] [Related]
14. Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher-Bickerstaff syndrome).
Yuki N
J Neuroimmunol; 2009 Oct; 215(1-2):1-9. PubMed ID: 19643503
[TBL] [Abstract][Full Text] [Related]
15. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases.
Larue S; Bombelli F; Viala K; Neil J; Maisonobe T; Bouche P; Musset L; Fournier E; Léger JM
Eur J Neurol; 2011 Jun; 18(6):899-905. PubMed ID: 21199182
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Monoclonal Antibody Therapies in Chronic Autoimmune Demyelinating Neuropathies.
Briani C; Visentin A
Neurotherapeutics; 2022 Apr; 19(3):874-884. PubMed ID: 35349079
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory neuropathies.
Whitesell J
Semin Neurol; 2010 Sep; 30(4):356-64. PubMed ID: 20941668
[TBL] [Abstract][Full Text] [Related]
18. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute immune-mediated neuropathies: Guillain-Barré syndrome and clinical variants.
Sederholm BH
Semin Neurol; 2010 Sep; 30(4):365-72. PubMed ID: 20941669
[TBL] [Abstract][Full Text] [Related]
20. Progressive subacute Miller-Fisher syndrome successfully treated with plasmapheresis.
Ejma M; Waliszewska-Prosół M; Hofman A; Budrewicz S; Podemski R; Bilińska M; Koszewicz M
Neurol Neurochir Pol; 2015; 49(2):137-8. PubMed ID: 25890931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
